Filing Details

Accession Number:
0001477932-23-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-04 16:16:00
Reporting Period:
2022-12-30
Accepted Time:
2023-01-04 16:16:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1443863 Biocorrx Inc. BICX Services-Specialty Outpatient Facilities, Nec (8093) 900967447
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1539788 C. Louis Lucido 2390 East Orangewood Avenue
Suite 500
Anaheim CA 92806
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2022-12-30 200 $0.98 89,625 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2022-12-30 115 $1.03 89,740 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2022-12-30 5,319 $0.00 95,059 No 4 A Direct
Common Stock, Par Value $0.001 Acquisiton 2023-01-03 2,000 $1.10 97,059 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 A Direct
No 4 P Direct
Footnotes
  1. These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94